CN102406776B - Traditional Chinese preparation for treating qi deficiency and blood stasis type coronary heart disease angina - Google Patents

Traditional Chinese preparation for treating qi deficiency and blood stasis type coronary heart disease angina Download PDF

Info

Publication number
CN102406776B
CN102406776B CN201110388238.2A CN201110388238A CN102406776B CN 102406776 B CN102406776 B CN 102406776B CN 201110388238 A CN201110388238 A CN 201110388238A CN 102406776 B CN102406776 B CN 102406776B
Authority
CN
China
Prior art keywords
parts
traditional chinese
heart disease
deficiency
blood stasis
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CN201110388238.2A
Other languages
Chinese (zh)
Other versions
CN102406776A (en
Inventor
宋爱民
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Nantong Mingjian Biotechnology Co ltd
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN201110388238.2A priority Critical patent/CN102406776B/en
Publication of CN102406776A publication Critical patent/CN102406776A/en
Application granted granted Critical
Publication of CN102406776B publication Critical patent/CN102406776B/en
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Landscapes

  • Medicines Containing Plant Substances (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

The invention belongs to the field of traditional Chinese preparation, and particularly relates to a traditional Chinese preparation for treating qi deficiency and blood stasis type coronary heart disease angina. The traditional Chinese preparation is prepared from the following traditional Chinese medicine raw materials in parts by weight: 3 parts of ginseng, 2 parts of rhizoma ligustici wallichii, 2 parts of spatholobus stem, 2 parts of acorus gramineus, 3 parts of hawthorn and 2 parts of motherwort, and has the effects of invigorating qi and promoting blood circulation, removing phlegm and promoting the circulation of qi as well as eliminating stagnation to activate Yang. The traditional Chinese preparation is researched by combining the diagnosis and treatment based on an overall analysis of the illness and the patient condition of traditional Chinese medicine with clinical practices, and has the characteristics of definite treatment effect, safety and convenience, rapid action, and no toxic or side effect.

Description

The anginal Chinese medicine preparation for the treatment of coronary heart disease with qi deficiency and blood stasis
Technical field
The invention belongs to field of traditional Chinese, particularly a kind of anginal Chinese medicine preparation of coronary heart disease with qi deficiency and blood stasis for the treatment of.
Background technology
Angina pectoris is coronary insufficiency, cardiac muscle sharply, temporary transient ischemia, the caused clinical symptoms of anoxia, for one of main Types of coronary atherosclerotic heart disease, this patient has hyperlipidemia more, hypertension, smoking and hereditary medical history, overworked, anxious state of mind, catch cold, be satiated with food etc. as the common cause of disease of bringing out, clinical manifestation is paroxysmal, anterior pectorial region squeezing property, vexed swollen property or asphyxiating pain, mainly be positioned at breastbone rear portion, can emit to pareordia, left upper extremity, while often betiding work or anxious state of mind, continue several minutes, transference cure after having a rest.Primary disease belongs to the category of Chinese medicine " thoracic obstruction ", " pained ", the angina pectoris that the present invention treats belongs to insufficiency of heart-QI, the turbid numbness resistance of blood stasis expectorant heart arteries and veins type, the main pathogenesis of primary disease is that motive virtual loss, expectorant are turbid, Yu Xue Bi resistance heart arteries and veins, the traditional Chinese medical science has obtained good effect by Coryza Treated by Syndrome Differentiation clinically, invents a kind of not only safe but also effective Chinese medicine preparation very necessary.
Summary of the invention
The object of this invention is to provide a kind of anginal Chinese medicine preparation of coronary heart disease with qi deficiency and blood stasis for the treatment of, the feature that there is determined curative effect, safe ready, instant effect, has no side effect.
A kind of anginal Chinese medicine preparation of coronary heart disease with qi deficiency and blood stasis for the treatment of of the present invention, is characterized in that being made by the raw material of Chinese medicine of following parts by weight: 2 parts of 3 parts of Radix Ginsengs, 2 parts of Rhizoma Chuanxiongs, 2 parts of Caulis Spatholobis, 2 parts of Rhizoma Acori Graminei, 3 parts of Fructus Crataegis and Herba Leonuris.
The present invention can make acceptable various preparations on Chinese materia medica, preferably decoction.
Preparation method: take raw material by above-mentioned weight, clean roguing, be ground into coarse grain, put in multi-function extractor, decoct with water 2 times, the decocting that adds for the first time 10 times of medical material gross weights boils 2 hours, filter to get filtrate, the decocting that adds up for the second time 7 times of weight of medical material boils 1 hour, filters; Twice filtrate is mixed, in heat-sealing bag, 100 ℃ of high temperature sterilizes, every bag of 200ml.
Usage and consumption: oral, once a bag, day takes secondary, within 20 days, is a course for the treatment of.
Drug action mechanism of the present invention is as follows:
Radix Ginseng: strongly invigorating primordial QI, invigorating the spleen to benefit the lung, promote the production of body fluid, calm the nerves, this product has strongly invigorating primordial QI, recuperating depleted YANG and rescuing the patient from collapse, the multiple admittedly de-effect of arteries and veins, is usually used in the diseases such as cardiopalmus, insomnia of motive virtual loss.
Rhizoma Chuanxiong: blood-activating and qi-promoting, wind-expelling pain-stopping, the pungent loose temperature of this product is logical, can invigorate blood circulation and can circulation of qi promoting, and " be gas medicine in blood ", is the active drug for the treatment of angina pectoris.
Caulis Spatholobi: promoting the circulation of blood is enriched blood, relaxing muscles and tendons and activating QI and blood in the collateral.
Rhizoma Acori Graminei: resuscitation inducing and mind tranquilizing, removing dampness to restore normal function of the stomach, this product is pungent open bitter dry, temperature is logical, fragrance is walked to alter, not only have have one's ideas straightened out, mind calming, the merit of calming the nerves, and have removing dampness, eliminating phlegm to ward off dirty effect.
Fructus Crataegi: promoting digestion and removing stagnation, circulation of qi promoting dissipating blood stasis, this product temperature QI and blood of passing through, has the effect of blood circulation promoting and blood stasis dispelling, pain relieving.
Herba Leonuri: promoting blood flow to regulate menstruation, inducing diuresis to remove edema.This product hardship is let out the pungent blood system that falls apart, enters, and kind controlling such as stops at the disease in blood stasis.
Curative effect judgement:
Effective: subjective symptoms all disappears, after activity without any discomfort, normal ECG.
Effective: the symptoms such as ambition dull pain, sensation of oppression over the chest with shortness of breath obviously alleviate, after fatigue, there is cardiopalmus, the symptom such as uncomfortable in chest, after having a rest, symptom is improved, and electrocardiogram is roughly normal.
Invalid: symptom and sign is without improvement, before treatment.
Therapeutic outcome: treatment Treating Patients of Angina Pectoris 88 examples, take decoction of the present invention, once a bag, day takes secondary, within 20 days, is a course for the treatment of.Through three course of therapy, effective 43 examples, account for 49%, and effective 40 examples, account for 45%, and invalid 5 examples, account for 6%, total effective rate 94%.Shown in treatment, without any side effects to patient, three large routine tests and hepatic and renal function detect no abnormal phenomenon.
Below enumerate several model cases:
Case 1: patient Zheng, man, 45 years old, 5 years causes are uncomfortable in chest, chest pain is examined as coronary heart disease, do because of tired processus aboralis sense ambition dull pain battle array in May, 2008, sensation of oppression over the chest with shortness of breath, moving more so, nervous weak, from sweating, examine as angina pectoris, give after two courses for the treatment of of drug oral of the present invention treatment, symptom disappears completely, after activity without any discomfort, normal ECG, follows up a case by regular visits to half a year without recurrence.
Case 2: patient king so-and-so, man, 49 years old, sent out precordial fullness pain radiation and left upper extremity because of tired processus aboralis in July, 2008, with uncomfortable in chest, have palpitation, breathe hard, after Electrocardioscopy, examine as angina pectoris, give after two courses for the treatment of of drug oral of the present invention treatment, symptom disappears completely, after activity without any discomfort, normal ECG, follows up a case by regular visits to half a year without recurrence.
Case 3: patient Lee so-and-so, man, 56 years old, suffers from coronary heart disease more than 8 years, prominent sense is uncomfortable in chest because drinking in JIUYUE, 2009, chest pain, palpitation and short breath, Lai Zhenwo institute, examines on inspection as angina pectoris, gives drug oral of the present invention and treats after three courses for the treatment of, symptom disappears completely, after activity, without any discomfort, normal ECG, follows up a case by regular visits to half a year without recurrence.
The present invention has the following advantages:
The present invention develops in conjunction with clinical practice experience for many years on the basis of Traditional Chinese Medicine determination for the treatment of based on pathogenesis obtained through differentiation of symptoms and signs, all medicines amount to mutually there is benefiting QI for activating blood circulation, the effect of the circulation of qi promoting of reducing phlegm, activating stagnated YANG.Treatment angina pectoris has advantages of determined curative effect, safe ready, instant effect, has no side effect.
The specific embodiment
Below in conjunction with embodiment, the invention will be further described.
Embodiment
Decoction, takes raw material by weight: 2 parts of 3 parts of Radix Ginsengs, 2 parts of Rhizoma Chuanxiongs, 2 parts of Caulis Spatholobis, 2 parts of Rhizoma Acori Graminei, 3 parts of Fructus Crataegis and Herba Leonuris.
Preparation method: take raw material by above-mentioned weight, clean roguing, be ground into coarse grain, put in multi-function extractor, decoct with water 2 times, the decocting that adds for the first time 10 times of medical material gross weights boils 2 hours, filter to get filtrate, the decocting that adds up for the second time 7 times of weight of medical material boils 1 hour, filters; Twice filtrate is mixed, in heat-sealing bag, 100 ℃ of high temperature sterilizes, every bag of 200ml.

Claims (1)

1. a treatment coronary heart disease with qi deficiency and blood stasis anginal Chinese medicine preparation, is characterized in that being made by the raw material of Chinese medicine of following parts by weight: 2 parts of 3 parts of Radix Ginsengs, 2 parts of Rhizoma Chuanxiongs, 2 parts of Caulis Spatholobis, 2 parts of Rhizoma Acori Graminei, 3 parts of Fructus Crataegis and Herba Leonuris.
CN201110388238.2A 2011-11-29 2011-11-29 Traditional Chinese preparation for treating qi deficiency and blood stasis type coronary heart disease angina Expired - Fee Related CN102406776B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201110388238.2A CN102406776B (en) 2011-11-29 2011-11-29 Traditional Chinese preparation for treating qi deficiency and blood stasis type coronary heart disease angina

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201110388238.2A CN102406776B (en) 2011-11-29 2011-11-29 Traditional Chinese preparation for treating qi deficiency and blood stasis type coronary heart disease angina

Publications (2)

Publication Number Publication Date
CN102406776A CN102406776A (en) 2012-04-11
CN102406776B true CN102406776B (en) 2014-04-02

Family

ID=45909313

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201110388238.2A Expired - Fee Related CN102406776B (en) 2011-11-29 2011-11-29 Traditional Chinese preparation for treating qi deficiency and blood stasis type coronary heart disease angina

Country Status (1)

Country Link
CN (1) CN102406776B (en)

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1334121A (en) * 2001-08-31 2002-02-06 石家庄以岭药业有限公司 Medicinal composition for restoring cardiac collaterals and its application

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1334121A (en) * 2001-08-31 2002-02-06 石家庄以岭药业有限公司 Medicinal composition for restoring cardiac collaterals and its application

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
治疗冠心病中药使用频率的研究分析;黄素芳等;《中药新药与临床药理》;20090725;第20卷(第04期);395-396 *
通脉法在治疗心血管疾病中的应用;韩瑞卿;《湖南中医药导报》;20011130;第07卷(第11期);540-541 *
韩瑞卿.通脉法在治疗心血管疾病中的应用.《湖南中医药导报》.2001,第07卷(第11期),540-541.
黄素芳等.治疗冠心病中药使用频率的研究分析.《中药新药与临床药理》.2009,第20卷(第04期),395-396.

Also Published As

Publication number Publication date
CN102406776A (en) 2012-04-11

Similar Documents

Publication Publication Date Title
CN102614422A (en) Traditional Chinese medical decoction for treatment of acute gouty arthritis
CN102357177B (en) Traditional Chinese medicine for curing climacteric metancholia
CN104013919A (en) Traditional Chinese medicine for treating angina pectoris
CN102133288B (en) Chinese herbal preparation for curing angina
CN103230457B (en) A kind of Chinese medicine composition treating viral myocarditis and preparation method thereof and purposes
CN103007214B (en) Chinese medicinal composition for treating palpitation
CN103550688B (en) A kind of Chinese medicine composition for the treatment of cardiopalmus
CN102716334A (en) Chinese medicinal composition for dispelling the cold and removing stasis
CN102327436A (en) Traditional Chinese medicine composition for treating edema during menstruation
CN103028089B (en) Traditional Chinese medicine composition for treating waist pains of middle-aged and old people
CN102512647B (en) Chinese herbal composition for treating abdominal pain due to deficiency-cold
CN102125664B (en) Chinese medicinal preparation for treating cervical spondylosis
CN104825956A (en) Medicine for preventing and treating stroke and recovering muscles, bones and joints
CN102293946A (en) Chinese medicinal composition for treating vertigo
CN102406776B (en) Traditional Chinese preparation for treating qi deficiency and blood stasis type coronary heart disease angina
CN104888133A (en) Traditional Chinese medicine composition for treatment of coronary heart disease
CN104524397A (en) Traditional Chinese medicine composition for assisted rehabilitation of stroke and preparation method of composition
CN102406704B (en) Chinese medicinal preparation for treating ankylosing spondylitis
CN107412679A (en) Detoxifying health-care product and its preparation method and application
CN102441096B (en) Disperse blood stasis and dredge collateral compound recipe pill and preparation method thereof
CN102125603A (en) Traditional Chinese medicinal preparation for treating intervertebral disc herniation
CN104758889A (en) Traditional Chinese medicine composition for treating diabetes
CN104435176B (en) Soothing the liver medicament and the preparation method of expelling the heat-evil of stamp hypertension on liver-heat
CN104667040A (en) Traditional Chinese medicine composition for treating palpitation
CN104758888A (en) Traditional Chinese medicine composition for treating diabetes

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
ASS Succession or assignment of patent right

Owner name: NANTONG MINGJIAN BIOTECHNOLOGY CO., LTD.

Free format text: FORMER OWNER: SONG AIMIN

Effective date: 20141120

C41 Transfer of patent application or patent right or utility model
COR Change of bibliographic data

Free format text: CORRECT: ADDRESS; FROM: 256100 ZIBO, SHANDONG PROVINCE TO: 226500 NANTONG, JIANGSU PROVINCE

TR01 Transfer of patent right

Effective date of registration: 20141120

Address after: 226500, C, room 999, Wan Sheng Nan Road, Chengnan street, Rugao, Jiangsu, Nantong 803, China

Patentee after: NANTONG MINGJIAN BIOTECHNOLOGY Co.,Ltd.

Address before: 256100 Yiyuan people's Hospital, Zibo, Shandong, China

Patentee before: Song Aimin

CF01 Termination of patent right due to non-payment of annual fee
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20140402